| Literature DB >> 30420891 |
Ya-Xin Han1, Peng-Fei Wang2,3, Meng Zhao2,4, Liang-Mian Chen2, Zhi-Min Wang2, Xiao-Qian Liu2, Hui-Min Gao2, Mu-Xin Gong1, Hui Li2, Ji-Zhong Zhu5, Chuan-Gui Liu5.
Abstract
Xueshuan Xinmaining Tablet (XXT) is a widely used traditional Chinese medicine for the treatment of stroke, chest pain, coronary heart disease, and angina pectoris caused by blood stasis. Having a multiple-component preparation, it is still far from meeting the requirements of modernization and standardization because its detailed chemical basis and action mechanism have not been clarified. In this work, the different batches of XXT samples were analyzed by HPLC and the typical sample was analyzed by UPLC-ESI-Q-TOF/MS to understand its chemical profiling. As a result, 77 chromatographic peaks were detected, among which 63 constituents were identified or tentatively characterized based on the comparison of retention time and UV spectra with authentic compounds as well as by summarized MS fragmentation rules and matching of empirical molecular formula with those of published components. This is the first systematic report on the chemical profiling of the commercial XXT products, which provides the sufficiently chemical evidence for the global quality evaluation of XXT products.Entities:
Year: 2018 PMID: 30420891 PMCID: PMC6215575 DOI: 10.1155/2018/2781597
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Structures of the identified compounds in XXT sample.
Figure 2HPLC profiles of Xueshuan Xinmaining Tablet samples at 251 nm (from top to bottom: Lot. 160904, 160905, 161001-161008).
Figure 3TICs of Xueshuan Xinmaining Tablet in the negative and positive modes.
Retention time (tR), UV, and MS data of the identified compounds in XXT samples.
| No. | tR/min | UV | Identified compounds | Formula | [M+H]+/[M+Na]+ | Calc.mass | Δppm | [M-H]− | Calc.mass | Δppm | [M+HCOO]−/[2M-H]− | Calc.mass | Δppm | Sourcea |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||||
| 1 | 1.03 | 282 | danshensu | C9H10O5 | 197.0446 | 197.0450 | -2.5 | /395.0974 | 395.0978 | -1.0 | DS | |||
| 2 | 1.22 | 295 | neochlorogenic acid | C16H18O9 | 353.0869 | 353.0873 | -1.1 | DS/MDQ | ||||||
| 3 | 1.59 | suberyl arginine | C14H26O5N4 | 331.1977/ | 331.1981 | -1.2 | 329.1819 | 329.1825 | -1.8 | CS | ||||
| 4 | 1.83 | 320 | chlorogenic acid | C16H18O9 | 355.1026/ | 355.1029 | -0.8 | 353.0876 | 353.0873 | 0.8 | /707.1840 | 707.1823 | 2.4 | DS/MDQ |
| 5 | 1.83 | 220, 318 | protocatechuic aldehyde | C7H6O3 | 137.0235/ | 137.0239 | -2.9 | DS | ||||||
| 6 | 1.99 | 233 | cryptochlorogenic acid | /377.0854 | 353.0871 | DS/MDQ | ||||||||
| 7 | 2.28 | 232, 318 | caffeic acid | C9H8O4 | 179.0341 | 179.0344 | -1.7 | DS | ||||||
| 8 | 3.41 | 244, 329 | unidentified | /465.1384 | 441.1395 | |||||||||
| 9 | 3.68 | 254, 352 | rutin | C27H30O16 | 611.1618/ | 611.1612 | 1.0 | 609.1458 | 609.1456 | 0.3 | /1219.3020 | 1219.2989 | 2.5 | HH |
| 10 | 4.31 | 264, 343 | kaempferol-3-O- | C27H30O15 | 595.1652/ | 595.1663 | -1.8 | 593.1505 | 593.1506 | -0.1 | HH | |||
| rutinoside | /617.1472 | 617.1482 | -1.6 | |||||||||||
| 11 | 4.35 | 244, 327 | isochlorogenic acid B | C25H24O12 | 517.1331/ | 517.1346 | -2.9 | 515.1188 | 515.1190 | -0.4 | DS/MDQ | |||
| /539.1177 | 539.1165 | 2.2 | ||||||||||||
| 12 | 4.39 | 244, 327 | salvianolic acid H | C27H22O12 | 539.1149/ | 539.1190 | -7.6 | 537.1031 | 537.1033 | -0.4 | DS | |||
| 13 | 4.42 | 252, 339 | isorhamnetin 3-O-rutinoside | C28H32O16 | 625.1754/ | 625.1769 | -2.4 | 623.1616 | 623.1612 | 0.6 | HH | |||
| /647.1578 | 647.1588 | -1.5 | ||||||||||||
| 14 | 4.50 | 329 | isochlorogenic acid A | C25H24O12 | /539.1154 | 539.1165 | -2.0 | 515.1193 | 515.1190 | 0.6 | DS/MDQ | |||
| 15 | 4.90 | 244, 326 | isochlorogenic acid C | C25H24O12 | 517.1359/ | 517.1346 | 2.5 | 515.1192 | 515.1190 | 0.4 | DS/MDQ | |||
| /539.1176 | 539.1165 | 2.0 | ||||||||||||
| 16 | 5.02 | 244, 329 | rosmarinic acid | C18H16O8 | 359.0766 | 359.0767 | -0.3 | /719.1610 | 719.1612 | -0.3 | DS | |||
| 17 | 5.13 | 250, 306 | salvianolic acid G | C18H12O7 | 341.0666/ | 341.0661 | 1.5 | DS | ||||||
| 18 | 5.17 | 251, 317 | salvianolic acid A | C26H22O10 | 493.1134 | 493.1135 | 0.2 | DS | ||||||
| 19 | 5.28 | gamabufotalin | C24H34O5 | 403.2483/ | 403.2484 | -0.2 | 447.2381/ | 447.2383 | -0.4 | CS | ||||
| 20 | 5.32 | bufarenogin | C24H32O6 | 417.2273/ | 417.2277 | -1.0 | CS | |||||||
| 21 | 5.43 | 276 | 4-hydroxyl-3-butylphthalide | C12H14O3 | 207.1024/ | 207.1021 | 1.4 | CX | ||||||
| 22 | 5.53 | 232 | salvianolic acid B | C36H30O16 | 717.1475 | 717.1456 | 2.6 | DS | ||||||
| 23 | 6.17 | ginsenoside Rg1 | C42H72O14 | /823.4792 | 823.4820 | -3.4 | 845.4905/ | 845.4899 | 0.7 | RSZZG | ||||
| 24 | 6.24 | ginsenoside Re | C48H82O18 | /969.5378 | 969.5399 | -2.2 | 945.5450 | 945.5423 | 2.9 | 991.5548/ | 991.5478 | 7.1 | RSZZG | |
| 25 | 6.44 | arenobufagin | C24H32O6 | 417.2271/ | 417.2277 | -1.4 | 415.2111 | 415.2121 | -2.4 | 461.2168/ | 461.2175 | -1.5 | CS | |
| 26 | 6.45 | quercetin | C15H10O7 | 303.0506/ | 303.0505 | 0.3 | 301.0346 | 301.0348 | -0.7 | HH | ||||
| 27 | 6.71 | unidentified | 765.2371 | |||||||||||
| 28 | 6.99 | unidentified | /677.4221 | 699.4323/ | ||||||||||
| 29 | 7.17 | 245, 328 | hellebrigenin | C24H32O6 | 417.2274 | 417.2277 | -0.7 | 461.2173/ | 461.2175 | CS | ||||
| 30 | 7.25 | unidentified | 677.1508 | |||||||||||
| 31 | 7.49 | tanshindiol A | C18H16O5 | 313.1079/ | 313.1076 | 1.0 | DS | |||||||
| /335.0901 | 335.0895 | 1.8 | ||||||||||||
| 32 | 8.14 | ethyl lithospermate | C29H26O12 | 567.1498/ | 567.1503 | -0.9 | 565.1342 | 565.1346 | -0.1 | DS | ||||
| /589.1320 | 589.1322 | -0.3 | ||||||||||||
| 33 | 8.49 | unidentified | /755.1589 | 731.1622 | ||||||||||
| 34 | 8.65 | unidentified | /1117.5740 | 1139.5891/ | ||||||||||
| 35 | 9.01 | 20 | C48H82O19 | /985.5332 | 985.5348 | -1.6 | 1007.5457/ | 1007.5427 | 3.0 | RSZZG | ||||
| 36 | 9.15 | beads ginseng saponins F1 | C48H82O19 | /985.5319 | 985.5348 | -2.9 | 1007.5457/ | 1007.5427 | 3.0 | RSZZG | ||||
| 37 | 9.26 | notoginsenoside R3 | C48H82O19 | /985.5339 | 985.5348 | -0.9 | 1007.5459/ | 1007.5427 | 3.2 | RSZZG | ||||
| 38 | 9.35 | unidentified | /951.4901 | 973.5042/ | ||||||||||
| 39 | 9.52 | unidentified | /538.2797 | 514.2904 | /1029.5789 | |||||||||
| 40 | 9.64 | ginsenoside Rf | C42H72O14 | 801.4985/ | 801.5000 | -1.9 | 845.4923/ | 845.4899 | 2.8 | RSZZG | ||||
| /823.4802 | 823.4820 | -2.2 | ||||||||||||
| 41 | 9.72 | bufotalin | C26H36O6 | 445.2588/ | 445.2590 | -0.4 | 489.2489/ | 489.2488 | 0.2 | CS | ||||
| 42 | 9.93 | notoginsenoside R2 | C41H70O13 | /793.4705 | 793.4714 | -1.1 | 815.4818/ | 815.4793 | 2.5 | RSZZG | ||||
| 43 | 10.07 | ginsenoside F3 | C41H70O13 | /793.4700 | 793.4714 | -1.8 | 815.4820/ | 815.4793 | 3.3 | RSZZG | ||||
| 44 | 10.10 | ginsenoside Rc | C53H90O22 | /1101.5831 | 1101.5821 | 0.9 | 1123.5947/ | 1123.5900 | 4.2 | RSZZG | ||||
| 45 | 10.20 | ginsenoside Rg2 | C42H72O13 | /807.4908 | 807.4871 | 4.3 | 829.4968/ | 829.4949 | 2.3 | RSZZG | ||||
| 46 | 10.31 | ginsenoside Rb2 | C53H90O22 | /1101.5798 | 1101.5821 | -2.1 | 1123.5952/ | 1123.5900 | 4.6 | RSZZG | ||||
| 47 | 10.38 | ginsenoside Rb3 | C53H90O22 | /1101.5797 | 1101.5821 | -2.2 | 1123.5940/ | 1123.5900 | 3.6 | RSZZG | ||||
| 48 | 10.49 | unidentified | 466.3162/ | 464.3032 | ||||||||||
| 49 | 10.75 | 20 | C36H62O9 | /661.4288 | 661.4292 | -0.6 | 683.4393/ | 683.4370 | 3.4 | RSZZG | ||||
| 50 | 10.73 | bufalin | C24H34O4 | 387.2531/ | 387.2535 | -1.0 | CS | |||||||
| 51 | 10.86 | unidentified | /969.5361 | 969.5399 | -3.9 | 991.5539/ | 991.5478 | 6.2 | ||||||
| 52 | 10.99 | unidentified | 503.3368/ | 501.3224 | ||||||||||
| 53 | 11.27 | ginsenoside Rd | C48H82O18 | /969.5374 | 969.5399 | -2.6 | 991.5509/ | 991.5478 | 3.1 | RSZZG | ||||
| 54 | 11.61 | gypenoside IX | C47H80O17 | /939.5284 | 939.5293 | -1.0 | 961.5390/ | 961.5372 | 1.9 | RSZZG | ||||
| 55 | 11.68 | resibufogenin | C24H32O4 | 385.2385/ | 385.2379 | 1.6 | CS | |||||||
| 56 | 11.71 | cinobufagin | C26H34O6 | 443.2435/ | 443.2434 | 0.2 | CS | |||||||
| 57 | 11.79 | cholic acid | C24H40O5 | /431.2778 | 431.2773 | 1.2 | 407.2803 | 407.2797 | 1.5 | 453.2857/ | 453.2852 | 1.1 | RGNH | |
| /815.5698 | 815.5673 | 3.1 | ||||||||||||
| 58 | 12.03 | ursodeoxycholic acid | C24H40O4 | 391.2851 | 391.2848 | 0.8 | 437.2902/ | 437.2903 | 1.4 | RGNH | ||||
| /783.5796 | 783.5775 | 2.6 | ||||||||||||
| /783.5778 | 783.5775 | 0.4 | ||||||||||||
| 59 | 12.41 | 1-oxo tanshinone IIA | C19H16O4 | 309.1134/ | 309.1127 | 2.3 | DS | |||||||
| 60 | 12.59 | ginsenoside Rk1 | C42H70O12 | /789.4742 | 789.4765 | -2.9 | 811.4871/ | 811.4844 | 3.3 | RSZZG | ||||
| 61 | 12.66 | 20 | C42H72O13 | /807.4860 | 807.4871 | -1.4 | 829.4964/ | 829.4949 | 1.8 | RSZZG | ||||
| 62 | 12.89 | neotanshinone D | C21H20O4 | 337.1431/ | 337.1440 | -2.7 | DS | |||||||
| 63 | 13.25 | dihydrotanshinone | C18H14O3 | 279.1033/ | 279.1021 | 4.3 | DS | |||||||
| /301.0849 | 301.0841 | 2.7 | ||||||||||||
| 64 | 13.52 | 20 | C42H72O13 | /807.4858 | 807.4871 | -2.1 | 829.4963/ | 829.4949 | 1.7 | RSZZG | ||||
| 65 | 13.71 | 20 | /807.4852 | 807.4871 | -2.4 | 829.4968/ | 829.4949 | 2.3 | RSZZG | |||||
| 66 | 13.76 | tetrahydro-tanshinone I | C18H16O3 | 281.1189/ | 281.1178 | 3.9 | DS | |||||||
| /303.1004 | 303.0997 | 2.3 | ||||||||||||
| 67 | 13.85 | hyodeoxycholic acid | C24H40O4 | 391.2852 | 391.2848 | 1.0 | 437.2903/ | 437.2903 | 0.0 | RGNH | ||||
| /783.5792 | 783.5775 | 2.2 | ||||||||||||
| 68 | 13.92 | unidentified | 503.3368/ | 501.3222 | /1003.6544 | |||||||||
| 69 | 13.98 | methyl tanshinonate | C20H18O5 | 339.1240/ | 339.1232 | 2.4 | DS | |||||||
| /361.1054 | 361.1052 | 1.4 | ||||||||||||
| 70 | 14.15 | chenodeoxycholic acid | C24H40O4 | 391.2848 | 391.2848 | 0.0 | 437.2901/ | 437.2903 | -0.5 | RGNH | ||||
| /783.5789 | 783.5775 | 1.8 | ||||||||||||
| 71 | 15.05 | cryptotanshinone | C19H20O3 | 297.1508/ | 297.1491 | 5.7 | DS | |||||||
| /319.1313 | 319.1310 | 0.9 | ||||||||||||
| 72 | 15.62 | ilexoside A/D | C42H70O12 | /789.4742 | 789.4765 | -2.9 | 811.4847/ | 811.4844 | 0.4 | MDQ | ||||
| 73 | 15.69 | 293 | methylene | C18H14O3 | 279.1030/ | 279.1021 | 3.2 | DS | ||||||
| tanshinquinone | /301.0848 | 301.0841 | 2.3 | |||||||||||
| 74 | 16.03 | 20 | C36H62O8 | 667.4425/ | 667.4421 | 0.6 | RSZZG | |||||||
| 75 | 16.39 | unidentified | 496.3405/ | 540.3302/ | ||||||||||
| 76 | 16.81 | 267 | tanshinone IIA | C19H18O3 | 295.1361/ | 295.1334 | 9.1 | DS | ||||||
| /317.1165 | 317.1154 | 3.5 | ||||||||||||
| 77 | 17.31 | miltirone | C19H22O2 | 283.1709/ | 283.1698 | 3.9 | DS | |||||||
| /305.1525 | 305.1517 | 2.6 |
a Danshen, Huaihua, Maodongqing, Chansu, Chuanxiong, Renshen Jingye Zongzaogan, and Rengong Niuhuang are abbreviated as DS, HH, MDQ, CS, CX, RSZZG, and RGNH, respectively.
Figure 4Proposed fragmentation pathway of ginsenoside Rb3.
Figure 5Proposed fragmentation pathway of gamabufotalin.
Figure 6Proposed fragmentation pathway of tanshinone IIA.